CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.70 USD
-0.05 (-2.86%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Brokerage Reports
CytomX Therapeutics, Inc. [CTMX]
Reports for Purchase
Showing records 141 - 151 ( 151 total )
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Top Picks for 2018
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Platform Continues to Broaden Ahead of Data- Rich 2018
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
CTMX Adds AMGN to the Partner List with Bispecific Collaboration
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: CytomX Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating coverage with an OUTPERFORM and $26 price target
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R